Thu, September 26, 2024
Wed, September 25, 2024
Tue, September 24, 2024
Mon, September 23, 2024
Fri, September 20, 2024

Jason Mc Carthy Maintainedzvraat Strong Buywith Increased Targetto 25on Sep 24th 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ywith-increased-targetto-25on-sep-24th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jason McCarthy of Maxim Group, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $18 to $25 on, Sep 24th, 2024.

Jason has made no other calls on ZVRA in the last 4 months.



There are 3 other peers that have a rating on ZVRA. Out of the 3 peers that are also analyzing ZVRA, 0 agree with Jason's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jason


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, September 20th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024